Form 4 for INKT MiNK Therapeutics, Inc.
Accepted 2023-05-05 00:00:00 ET · period of report 2023-05-03 · accession 0000950170-23-018401 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-05 | 2023-05-03+ | INKT | AGENUS INC | 10% | P - Purchase | $1.04 | +250.4K | 21.59M | +1% | +$260.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-05 | P | A | 200 | $1.25 | 21,595,047 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-03 | P | A | 128,689 | $1.08 | 21,473,374 | D | — | — | (F2) Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F1) Open market purchases reported on this line occurred at a weighted average price of $1.0789 (range of $0.9144 to $1.20). |
| 3 | Common | Common Stock | 2023-05-04 | P | A | 21,473 | $1.22 | 21,494,847 | D | — | — | (F2) Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F3) Open market purchases reported on this line occurred at a weighted average price of $1.0789 (range of $1.20 to $1.25). |
| 4 | Common | Common Stock | 2023-05-05 | P | A | 100,000 | $0.95 | 21,594,847 | D | — | — |